American Enterprise Institute (AEI) economist  Roger Bate shares his expertise on counterfeit drug networks that pose a growing threat to combating diseases like malaria.

In an attempt to protect poor, uninsured and underinsured Americans from unsafe drugs, we are making sure that some go without drugs completely. It is time the law was changed.

In a just-published op-ed in the New York Times, American Enterprise Institute (AEI) international health economist Roger Bate highlights a better way to fight fake pharmaceuticals while still giving poor Americans access to less costly drugs from online pharmacies.

Since there is no demand for dangerous medicine, international action has a far greater chance of success than the war against narcotics.

With fakes of the cancer drug Avastin popping up in U.S. clinics in the past few months, patients are naturally worried about whether their medicines are safe.  Considering eighty percent of the ingredients in U.S. medicines come from overseas – mostly from China and India because their products are generally...

Substandard and counterfeit drugs can be lethal to patients and accelerate drug resistance across at-risk populations.